page_banner

Products

(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl) tetrahydro-2H-pyran-3,4,5-triyl triacetatis CAS; 461432-25-7

Description:

Catalogue Number: XD93361
Cas: 461432-25-7
Formulae hypotheticae: C29H33ClO10
Pondus hypotheticum: 577.02
Availability: In Stock
Pretium:  
Prepack:  
Mole Pack: Request Quote

 


Product Detail

Product Tags

Catalogue Number XD93361
Product Name (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl) tetrahydro-2H-pyran-3,4,5-triyl triacetate
CAS 461432-25-7
Formulae hypotheticaela C29H33ClO10
M. Pondus 577.02
Repono Details Ambiens

 

Product Specification

Aspectus Pulvis albus
Assay 99% min

 

Compositum (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl) tetrahydro-2H-pyran-3,4,5-triyl triacetatum Moleculum organicum complexum est quod potentiale applicationes in pluribus locis chemiae et pharmaceuticae inquisitionis habet. Unus usus possibilis huius compositionis est in synthesi organica.Praesentia multiplex coetus functionis, incluso acetoxymethyl, chloro, et ethoxybenzyl, varios modos praebet ad moleculandum et modificandum.Chemici hac compositione uti possunt ut principium materiae ad componendam compositorum magis complexorum organicorum, sicut intermedia pharmaceutica vel derivativa producta naturalia.Per opportuna eligendo et modificando specifica coetus functiones, investigatores possunt proprietates compositi sarcire et augere suas optatas proprietates, ut biologicam activitatem vel solubilitatem. Alia applicationis potentialis (2R,3R,4R,5S,6S)-2-(acetoxymethyl)- 6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetatis in medicinali chemia jacet.Compositi compages varias notas in moleculis pharmacologice activis communiter reperit, sicut anulum pyranum et coetus aromaticus benzyl.Investigatores pharmaceutici explorare poten- tiam pharmacologicam huius compositi possunt, studentes suas interactiones cum scutis biologicis, studia structurae-activitatis relationis, aestimantes efficaciam therapeuticam.Praesentia coetus triacetatis praebere potest etiam alia beneficia, ut stabilitas emendata, aucta lipophilica, vel membrana permeabilitatis aucta, quae proprietates in medicamento progressu desiderabiles sunt. Praeterea unica stereochemistica compositi (2R,3R,4R,5S,6S) suam potentiam confert ut in synthesi asymmetrica chiralum clausus.Centra chiralia quae in moleculo sunt, occasionem praebent ad componendas compositiones puras enantiomericas, quae pendet in pharmaceuticis et agrochemicis producendis.Chemici organici hac compositione uti possunt tamquam materia chirali incipiens vel introducere illam in synthesim complexam viam ad puros fructus enantiomerice obtinendos. Interest notandum quod opus cum hoc composito requirit peritiam in tractandis et componendis moleculis organicis complexis.Investigatores cautiones opportunas adhibere debent et puritatem et rationem mixti ante usum. In summa, (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl )phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate promissio versatilis composita in synthesi organica, chemia medicinali et synthesi asymmetrica.Cum suis multiplicibus coetibus functionibus et stereochemistica unica, opportunitates praebet ad progressionem novorum compositionum cum applicationibus potentialibus in variis scientiae campis, incluso medicamento inventionis, scientia materiali et biologiae chemica.


  • Priora:
  • Deinde:

  • Close

    (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl) tetrahydro-2H-pyran-3,4,5-triyl triacetatis CAS; 461432-25-7